SIR—Winston and Schiller [1] report the results of the analysis of their institutions's data from a multicenter, randomized study that compared amphotericin B lipid complex (ABLC; The Liposome Company) with conventional amphotericin B (CAB; Apothecon) as empiric therapy for febrile neutropenic patie...
No comments yet
Be the first to share your thoughts!